T. D. Zvyagintseva

Clinical trial: A novel high‐dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500‐mg suppository thrice daily in active ulcerative proctitis

M. Vieth, M. Stolte, I. Cascorbi, 2010, Inflammatory bowel diseases.

T1137 A Novel High Dose 1g Mesalamine Suppository (Salofalk®) Is As Efficacious As 500mg TID Suppositories in Mild to Moderate Active Ulcerative Proctitis: A Multicenter, Randomized Trial

A. Lavy, R. Greinwald, T. Andus, 2008 .